(Q35055189)

6 August 2017

1 reference

title

L-arginine in cardiovascular disease: dream or reality? (English)

1 reference

Christodoulos I. Stefanadis

6 August 2017

main subject

cardiovascular disease

1 reference

based on heuristic

inferred from title

author

series ordinal

5

object named as

Christodoulos Stefanadis

1 reference

6 August 2017

1

Dimitris Tousoulis

1 reference

6 August 2017

6

Pavios Toutouzas

1 reference

6 August 2017

4

George Goumas

1 reference

6 August 2017

3

Costas Tentolouris

1 reference

6 August 2017

author name string

Charalambos Antoniades

series ordinal

2

1 reference

6 August 2017

publication date

1 August 2002

1 reference

6 August 2017

1 reference

6 August 2017

volume

7

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

203-211

1 reference

L-Arginine in coronary atherosclerosis

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Nitric oxide in the pathogenesis of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Cellular and molecular mechanisms of endothelial cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Pharmacological concentrations of arginine influence human whole blood viscosity independent of nitric oxide synthase activity in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Arginine metabolism: nitric oxide and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Cardiovascular effects of L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Insulin and the arginine paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Effects of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilatation in the hypercholesterolemic rabbit. Response according to treatment duration, anatomic site, and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral L-arginine but not vitamin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Effects of L-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

L-arginine decreases infarct size in rats exposed to environmental tobacco smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

L-arginine partially reverses established adrenocorticotrophin-induced hypertension and nitric oxide deficiency in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Role of nitric oxide in adrenocorticotrophin-induced hypertension: L-arginine effects reversed by N-nitro-L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

L-Arginine improves endothelial function in renal artery of hypertensive Dahl rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Secondary endothelial dysfunction: hypertension and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

L-arginine enhances aerobic exercise capacity in association with augmented nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Endothelial dysfunction in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Increased L-arginine uptake and inducible nitric oxide synthase activity in aortas of rats with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

L-arginine reduces heart rate and improves hemodynamics in severe congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Endothelial dysfunction in hypercholesterolemia is reversed by a nutritional product designed to enhance nitric oxide activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Oral L-arginine administration attenuates postprandial endothelial dysfunction in young healthy males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Effects of oral L-arginine on plasma nitrate and blood pressure in cortisol-treated humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Mechanisms underlying endothelial dysfunction in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Nitric oxide modulation of neutrophil-endothelium interaction: difference between arterial and venous coronary bypass grafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

L-Arginine normalizes coronary vasomotion in long-term smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Effect of L-arginine infusion on systemic and renal hemodynamics in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Does ADMA cause endothelial dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM434RA

10.1191/1358863X02VM434RA

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference